CNO — California Nanotechnologies Income Statement
0.000.00%
Last trade - 00:00
- CA$16.61m
- CA$16.89m
- $1.38m
- 72
- 34
- 56
- 54
2019 February 28th | 2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.75 | 0.831 | 0.795 | 1.08 | 1.38 |
Cost of Revenue | |||||
Gross Profit | 0.495 | 0.523 | 0.46 | 0.757 | 0.998 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.737 | 0.818 | 0.916 | 0.872 | 1.19 |
Operating Profit | 0.012 | 0.013 | -0.122 | 0.21 | 0.189 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.058 | -0.058 | -0.121 | 0.201 | 0.084 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.059 | -0.056 | -0.121 | 0.201 | 0.08 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.059 | -0.056 | -0.121 | 0.201 | 0.08 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.059 | -0.056 | -0.121 | 0.201 | 0.08 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.002 | -0.002 | -0.003 | 0.006 | 0.002 |